Psychometric validation of the 1-month recall Uterine Fibroid Symptom and Health-Related Quality of Life questionnaire (UFS-QOL)

Journal of Patient-Reported Outcomes

Table 4 Known groups validity: UFS-QOL scale scores by PGI-I response categories after 12 weeks of treatment in VENUS II: per protocol population (patient-reported outcome approach)

^aIncludes responses of “Very much better”, “Much better”, and “A little better”
^bIncludes response of “No change”
^cIncludes responses of “A little worse”, “Much worse”, and “Very much worse”
^dGeneral linear model – pairwise comparisons between means were performed using Scheffe’s test adjusting for multiple comparisons: *p < 0.05; **p < 0.01; ***p < 0.001; 1, “improved” versus “no change”; 2, “improved” versus “worsened”. The comparison between “no change” versus “worsened” was not significant for each scale. HRQoL health-related quality of life, PGI-I Patient Global Impression of Improvement scale, SD standard deviation, UFS-QOL Uterine Fibroid Symptom and Health-Related Quality of Life questionnaire